RecruitingNot ApplicableNCT04875884

Optimized MRI of Patients With Hip Arthroplasty


Sponsor

NYU Langone Health

Enrollment

22 participants

Start Date

Aug 11, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This is a single-center single-arm clinical trial with a paired design which compares the effectiveness of 3T MRI with (modified) and without (standard) radiofrequency pulse polarization optimization in reducing metal-related artifacts in patients with hip arthroplasty implants.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria5

  • Patients aged ≥ 18 with unilateral symptomatic (e.g. pain) total hip arthroplasty
  • Referred for MRI examination at the discretion of the treating physician
  • Provision of signed and dated informed consent form
  • No metal hardware in the body including contralateral hip arthroplasty
  • No contraindication to MRI: defined as claustrophobia or presence of other MRI-incompatible devices

Exclusion Criteria4

  • History of revision hip arthroplasty
  • Pregnancy (self-reported, or self-suspected)
  • Hip arthroplasty surgery within one year of enrollment
  • Clinical indication to administer intravenous contrast material during MRI

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEModified MRI

A technical modification to the standard MRI which only affects radiofrequency pulse polarization attempting to optimize the image quality. All other factors, including pulse sequence parameters, and patient and coil positioning is similar to that of the standard MRI.


Locations(1)

NYU Langone Radiology - Center for Biomedical Imaging

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04875884


Related Trials